COMPOUNDS AND METHODS FOR IMPROVING IMPAIRED ENDOGENOUS FIBRINOLYSIS USING HISTONE DEACETYLASE INHIBITORS
申请人:Larsson Pia
公开号:US20140051716A1
公开(公告)日:2014-02-20
There is provided a compound which is a histone deacetylase (HDAC) inhibitor, or a pharmaceutically acceptable ester, amide, solvate or salt thereof, for use in: (I) treating or preventing a pathological condition associated with excess fibrin deposition and/or thrombus formation; and/or (II) potentiating the degradation of fibrin deposits and preventing such deposits associated with pathological conditions or which may lead to such conditions, wherein the HDAC inhibitor, and the dose thereof, is as described in the description. There is also provided valproic acid, or a pharmaceutically acceptable salt thereof, for use in improving or normalizing endogenous fibrinolysis impaired by local or systemic inflammation.
Wacker-Type Oxidation and Dehydrogenation of Terminal Olefins Using Molecular Oxygen as the Sole Oxidant without Adding Ligand
作者:Yu-Fei Wang、Ya-Ru Gao、Shuai Mao、Yan-Lei Zhang、Dong-Dong Guo、Zhao-Lei Yan、Shi-Huan Guo、Yong-Qiang Wang
DOI:10.1021/ol500218p
日期:2014.3.21
An efficient and economical palladium-catalyzed oxidation system has been identified. The oxidation system, characterized by not adding ligand and usingmolecularoxygen as the sole oxidant, can realize the Tsuji–Wacker oxidation of terminalolefins and especially styrenes to methyl ketones; in addition, this system can achieve tandem Wacker oxidation–dehydrogenation of terminalolefins to α,β-unsaturated